Menu Search
Equities

China Resources Medical Holdings Company Ltd

1515:HKG.HZ

China Resources Medical Holdings Company Ltd

Actions
  • Price (HKD)3.82
  • Today's Change-0.06 / -1.55%
  • Shares traded3.27m
  • 1 Year change-38.19%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

China Resources Medical Holdings Company Ltd, formerly China Resources Phoenix Healthcare Holdings Company Ltd, is a China-based holding company mainly engaged in hospital business. The Company is engaged in providing comprehensive medical services, providing hospital management services, and selling medicines, medical devices and medical consumables, as well as providing other hospital derivative services to related hospitals. The Company operates in two segments. Hospital Business segment includes outpatient and inpatient services corresponding to its own hospitals. Other Business segment includes operation management services, supply chain services and other derivative services provided to joint-stock hospitals and IOT/OT hospitals. The Company mainly operates in the domestic market.

  • Revenue in HKD (TTM)10.93bn
  • Net income in HKD278.54m
  • Incorporated2013
  • Employees20.17k
  • Location
    China Resources Medical Holdings Company LtdE-825No. 6 Taiping Street, Xicheng DistrictBEIJING 100050ChinaCHN
  • Phone+86 1 059361058
  • Fax+86 1 059361935
  • Websitehttp://www.crmedical.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.